(Press-News.org) On average, a drug on the market works effectively for only 50% of the people who take it. Would you want to prevent a potential adverse drug effect or even toxicity through a simple test? It's not science fiction, but a reality. Pharmacogenetics (PGx) is the study of an individual's variation in DNA sequence related to drug response. The goal is to select the right drug at the right dose, and to avoid adverse drug reactions or ineffective treatment.
Dr. Tara Sander, Associate Professor of Pathology, Pediatric Pathology, Medical College of Wisconsin, and Scientific Director of Molecular Diagnostics, Children's Hospital of Wisconsin, is first author of a poster to be presented at Experimental Biology 2011 in Washington, DC, on Monday, April 11, in an American Society for Investigative Pathology session on "Better Research Through BioOmics." She led a study that aimed to develop a PGx test for forensics. The PGx test can be used on a living or deceased person; in cases of death, the test can help identify whether the drug toxicity was due to the person's genotype and therefore provide forensic evidence that supplements medical history, scene investigation, autopsy, and toxicology for death certification. Sander and colleagues looked at specific genetic variants to see if the selected assays detected the correct genotype in the samples. The results showed that ABI TaqMan Drug Metabolism Genotyping and Copy Number Variant assays detected the correct genotype in 52 of 54 samples with 96% accuracy.
Sander's clinical test refers to the promise of Personalized Medicine, a term used frequently by former NIH Director Elias Zerhouni to define the use of information about an individual patient to select or optimize their medical care. More recently, the term Personalized Justice has been defined as using genotypic information to complement Personalized Medicine and to help explain drug-related toxicity, sensitivity, impaired performance, and behavioral changes. These two ideas complement each other and can lead to better drug therapy.
"Moving forward, pharmacogenetics testing is at the forefront of reducing adverse drug reactions and increasing drug effectiveness. Hopefully more physicians will apply this to their drug treatment plans and reduce toxic cases/deaths," said Sander. Patients would ideally be tested in advance to determine which medications would work best and at what dosage.
"There are still cases in which a person receives the wrong drug or the wrong dose. With knowledge of their genotype, this could be avoided," said Sander. Because insufficient genotype-phenotype associations still remain, research needs to be done to show a direct correlation between variation and side effect for specific drugs. Sander hopes that clinical studies will further elucidate the correlation between the genetic variation and the studied phenotypic side effect.
###
About Experimental Biology 2011
Experimental Biology is an annual gathering of six scientific societies that this year is expected to draw 13,000-plus independent scientists and exhibitors. The societies represented are: American Association of Anatomists (AAA), American Physiological Society (APS), American Society for Biochemistry and Molecular Biology (ASBMB), American Society for Investigative Pathology (ASIP), American Society for Nutrition (ASN) and the American Society for Pharmacology and Experimental Therapeutics (ASPET).
About the American Society for Investigative Pathology
The American Society for Investigative Pathology (ASIP) is a society of biomedical scientists who investigate mechanisms of disease. Investigative pathology is an integrative discipline that links the presentation of disease in the whole organism to its fundamental cellular and molecular mechanisms. It uses a variety of structural, functional, and genetic techniques and ultimately applies research findings to the diagnosis and treatment of diseases. ASIP advocates for the practice of investigative pathology and fosters the professional career development and education of its members.
Pharmacogenetics testing offers way to reduce deaths from drug toxicity
2011-04-12
ELSE PRESS RELEASES FROM THIS DATE:
Empire Medical Training Offers Great New Way to Train Your Medical Staff - Send 3 Office Members at a Time
2011-04-12
Empire Medical Training - a recognized source for CME Education and Procedural Training for the past 10 years - knows how difficult it can be to schedule trainings for a larger practice. That's why they've created their Office Membership Program. A great new way to train staff, large practices can send up to three staff members to all of Empire's training programs - including their incredibly popular Advanced Aesthetic Workshop - over the course of two years - all for one incredibly low price.
About Empire Medical Training's Office Membership Program:
Instead of ...
Tissue engineers use new system to measure biomaterials, structures
2011-04-12
PROVIDENCE, R.I. [Brown University] — Tissue engineering makes biologists builders, but compared to their civil engineering counterparts, they don't know much about the properties of the materials and structures they use, namely living cells. To improve that knowledge, Brown University researchers have developed a simple and reliable system for measuring the power that cells employ to assemble into three-dimensional tissue. The research appears online the week of April 11 in Proceedings of the National Academy of Sciences.
In addition to helping engineers evaluate how ...
Distribution of cancers in the HIV/AIDS population is shifting
2011-04-12
As treatments for HIV/AIDS improve and patients are living longer, the distribution of cancers in this population has undergone a dramatic shift in the United States. While cases of the types of cancer that have been associated with AIDS progression have decreased, cases of other types of cancer are on the rise. These results, reported by scientists from the National Cancer Institute (NCI), part of the National Institutes of Health, and the Centers for Disease Control and Prevention, were published online April 11, 2011, in the Journal of the National Cancer Institute.
The ...
UCSF study on multitasking reveals switching glitch in aging brain
2011-04-12
Scientists at the University of California, San Francisco have pinpointed a reason older adults have a harder time multitasking than younger adults: they have more difficulty switching between tasks at the level of brain networks.
Juggling multiple tasks requires short-term, or "working," memory – the capacity to hold and manipulate information in the mind for a period of time. Working memory is the basis of all mental operations, from learning a friend's telephone number, and then entering it into a smart phone, to following the train of a conversation, to conducting ...
Brighter Future for Planet is The Goal as Sheraton Sharm El Sheikh Goes Dark for Earth Hour 2011
2011-04-12
By spending an hour in the dark on March 26th, Sheraton Sharm El Sheikh joined millions around the world to send a powerful message about a brighter future for the planet.
Sheraton Sharm El Sheikh turned off its lights in observance of Earth Hour, the global environmental awareness event created by the World Wildlife Fund (WWF). Last year, Earth Hour 2010 became the biggest Earth Hour ever. A record 128 countries and territories joined the global display of climate action. Iconic buildings and landmarks from Asia Pacific to Europe and Africa to the Americas switched ...
Combined use of 3 markers for kidney disease may help predict risk of kidney failure, death
2011-04-12
Combining the chronic kidney disease markers of creatinine-based estimated glomerular filtration rate and urine albumin-to-creatinine ratio with the biomarker cystatin C was associated with improved prediction of end-stage kidney disease and all-cause death, according to a study that will appear in the April 20 issue of JAMA. The study is being published early online to coincide with its presentation at the World Congress of Nephrology.
Chronic kidney disease (CKD) is currently defined as certain levels of creatinine-based estimated glomerular filtration rate (GFR) or ...
Routine lab test data predicts progression to kidney failure for chronic kidney disease patients
2011-04-12
A prediction model that included data on measures of several routinely obtained laboratory tests including blood levels of calcium, phosphate and albumin accurately predicted the short-term risk of kidney failure for patients with moderate to severe chronic kidney disease, according to a study that will appear in the April 20 issue of JAMA. The study is being published early online to coincide with its presentation at the World Congress of Nephrology.
"An estimated 23 million people in the United States (11.5 percent of the adult population) have chronic kidney disease ...
Evidence lacking for efficacy of memantine in treating mild Alzheimer's disease
2011-04-12
An analysis of studies involving the drug memantine finds a lack of
evidence for benefit when the drug is used to treat patients with mild
Alzheimer disease, according to a report posted online today that will
appear in the August print issue of Archives of Neurology, one of the
JAMA/Archives journals.
"Memantine, indicated for moderate to severe Alzheimer disease (AD), is frequently prescribed off-label [for uses other than those approved by the FDA] either alone or with a cholinesterase inhibitor for mild AD and mild cognitive impairment," the authors write as background ...
Automatic Network Backup Features in a New Version of Handy Backup by Novosoft
2011-04-12
Novosoft, an international software development and IT consultancy company, announced the release of a new version of Handy Backup. The program presents features (automatic registration and remote installation over Active Directory among others) to help system administrators configure backup plans for windows networks.
"Want me to tell you a secret of success in software development? I personally doubt there are "magic" formulas, but here is a thing that proved to be solely efficient: explore various applications of your concepts. Take Handy Backup. One of the major ...
Long-term use of antibiotic to treat acne not associated with increased bacterial resistance
2011-04-12
The prolonged use of tetracycline antibiotics commonly used to treat acne was associated with a reduced prevalence of StaphylococcuS. aureus bacteria and was not associated with increased resistance to the tetracycline antibiotics, according to a report posted online today that will appear in the August print issue of Archives of Dermatology, one of the JAMA/Archives journals.
StaphylococcuS. aureus is found in both hospital and community settings. "While S. aureus colonizes the skin, it can also be responsible for localized cutaneous infections and life-threatening systemic ...